(Total Views: 658)
Posted On: 10/26/2020 3:52:13 PM
Post# of 155568
As a follow up In case this hasnt been posted.
Quote
"Just last week, data from a U.S. government-led, placebo-controlled, double-blinded study showed remdesivir cut death rates by 70% in patients receiving low-flow oxygen and cut recovery time by 86% in severe patients."
Source:
https://www.fiercepharma.com/special-report/m...a-brainard
How can this be true based on all of the real data out there.
Sounds like someone is bending the rules to line Gilead's profits and shareholders stock price.
Quote
"Just last week, data from a U.S. government-led, placebo-controlled, double-blinded study showed remdesivir cut death rates by 70% in patients receiving low-flow oxygen and cut recovery time by 86% in severe patients."
Source:
https://www.fiercepharma.com/special-report/m...a-brainard
How can this be true based on all of the real data out there.
Sounds like someone is bending the rules to line Gilead's profits and shareholders stock price.
(2)
(0)
